{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T14:25:53Z","timestamp":1784211953057,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Natural Science Foundation of Shanghai","award":["23ZR1459500"],"award-info":[{"award-number":["23ZR1459500"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82371923"],"award-info":[{"award-number":["82371923"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82202285"],"award-info":[{"award-number":["82202285"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Science and Technology Commission of Shanghai Municipality","award":["23Y11907400"],"award-info":[{"award-number":["23Y11907400"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-024-11296-0","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T11:21:59Z","timestamp":1734607319000},"page":"4068-4079","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["MRI-based microvascular invasion prediction in mass-forming intrahepatic cholangiocarcinoma: survival and therapeutic benefit"],"prefix":"10.1007","volume":"35","author":[{"given":"Ruofan","family":"Sheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beixuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0030-9254","authenticated-orcid":false,"given":"Mengsu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"key":"11296_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.21037\/cco.2018.07.03","volume":"7","author":"AJ Lee","year":"2018","unstructured":"Lee AJ, Chun YS (2018) Intrahepatic cholangiocarcinoma: the AJCC\/UICC 8th edition updates. Chin Clin Oncol 7:52","journal-title":"Chin Clin Oncol"},{"key":"11296_CR2","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2214\/ajr.181.3.1810819","volume":"181","author":"JH Lim","year":"2003","unstructured":"Lim JH (2003) Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. AJR Am J Roentgenol 181:819\u2013827","journal-title":"AJR Am J Roentgenol"},{"key":"11296_CR3","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1002\/hep.30289","volume":"69","author":"AE Sirica","year":"2019","unstructured":"Sirica AE, Gores GJ, Groopman JD et al (2019) Intrahepatic cholangiocarcinoma: continuing challenges and translational advances. Hepatology 69:1803\u20131815","journal-title":"Hepatology"},{"key":"11296_CR4","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1245\/s10434-022-11463-x","volume":"29","author":"WJ Choi","year":"2022","unstructured":"Choi WJ, Williams PJ, Claasen M et al (2022) Systematic review and meta-analysis of prognostic factors for early recurrence in intrahepatic cholangiocarcinoma after curative-intent resection. Ann Surg Oncol 29:4337\u20134353","journal-title":"Ann Surg Oncol"},{"key":"11296_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.975136","volume":"12","author":"S Cremen","year":"2022","unstructured":"Cremen S, Kelly ME, Gallagher TK (2022) The role of neo-adjuvant therapy in cholangiocarcinoma: a systematic review. Front Oncol 12:975136","journal-title":"Front Oncol"},{"key":"11296_CR6","doi-asserted-by":"publisher","first-page":"6558","DOI":"10.1245\/s10434-023-13809-5","volume":"30","author":"SK Maithel","year":"2023","unstructured":"Maithel SK, Keilson JM, Cao HST et al (2023) NEO-GAP: a single-arm, phase II feasibility trial of neoadjuvant gemcitabine, cisplatin, and nab-paclitaxel for resectable, high-risk intrahepatic cholangiocarcinoma. Ann Surg Oncol 30:6558\u20136566","journal-title":"Ann Surg Oncol"},{"key":"11296_CR7","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1245\/s10434-020-09478-3","volume":"28","author":"O Utuama","year":"2021","unstructured":"Utuama O, Permuth JB, Dagne G et al (2021) Neoadjuvant chemotherapy for intrahepatic cholangiocarcinoma: a propensity score survival analysis supporting use in patients with high-risk disease. Ann Surg Oncol 28:1939\u20131949","journal-title":"Ann Surg Oncol"},{"key":"11296_CR8","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1159\/000522403","volume":"11","author":"S Kubo","year":"2022","unstructured":"Kubo S, Shinkawa H, Asaoka Y et al (2022) Liver Cancer Study Group of Japan clinical practice guidelines for intrahepatic cholangiocarcinoma. Liver Cancer 11:290\u2013314","journal-title":"Liver Cancer"},{"key":"11296_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1148\/radiol.2018171593","volume":"288","author":"A Pandey","year":"2018","unstructured":"Pandey A, Pandey P, Aliyari Ghasabeh M et al (2018) Unresectable intrahepatic cholangiocarcinoma: multiparametric MR imaging to predict patient survival. Radiology 288:109\u2013117","journal-title":"Radiology"},{"key":"11296_CR10","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.3390\/cells10082096","volume":"10","author":"FZ Ilyas","year":"2021","unstructured":"Ilyas FZ, Beane JD, Pawlik TM (2021) The state of immunotherapy in hepatobiliary cancers. Cells 10:2096","journal-title":"Cells"},{"key":"11296_CR11","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jhep.2019.10.009","volume":"72","author":"RK Kelley","year":"2020","unstructured":"Kelley RK, Bridgewater J, Gores GJ, Zhu AX (2020) Systemic therapies for intrahepatic cholangiocarcinoma. J Hepatol 72:353\u2013363","journal-title":"J Hepatol"},{"key":"11296_CR12","first-page":"7674","volume":"10","author":"C Shao","year":"2017","unstructured":"Shao C, Chen J, Chen J, Shi J, Huang L, Qiu Y (2017) Histological classification of microvascular invasion to predict prognosis in intrahepatic cholangiocarcinoma. Int J Clin Exp Pathol 10:7674\u20137681","journal-title":"Int J Clin Exp Pathol"},{"key":"11296_CR13","doi-asserted-by":"publisher","first-page":"5575","DOI":"10.7150\/jca.32199","volume":"10","author":"Z Tang","year":"2019","unstructured":"Tang Z, Liu WR, Zhou PY et al (2019) Prognostic value and predication model of microvascular invasion in patients with intrahepatic cholangiocarcinoma. J Cancer 10:5575\u20135584","journal-title":"J Cancer"},{"key":"11296_CR14","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1007\/s10147-023-02358-2","volume":"28","author":"K Toshida","year":"2023","unstructured":"Toshida K, Itoh S, Nakayama Y et al (2023) Preoperative HALP score is a prognostic factor for intrahepatic cholangiocarcinoma patients undergoing curative hepatic resection: association with sarcopenia and immune microenvironment. Int J Clin Oncol 28:1082\u20131091","journal-title":"Int J Clin Oncol"},{"key":"11296_CR15","first-page":"6971","volume":"37","author":"M Tsukamoto","year":"2017","unstructured":"Tsukamoto M, Yamashita YI, Imai K et al (2017) Predictors of cure of intrahepatic cholangiocarcinoma after hepatic resection. Anticancer Res 37:6971\u20136975","journal-title":"Anticancer Res"},{"key":"11296_CR16","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1007\/s11547-023-01704-8","volume":"128","author":"X Ma","year":"2023","unstructured":"Ma X, Qian X, Wang Q et al (2023) Radiomics nomogram based on optimal VOI of multi-sequence MRI for predicting microvascular invasion in intrahepatic cholangiocarcinoma. Radiol Med 128:1296\u20131309","journal-title":"Radiol Med"},{"key":"11296_CR17","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00261-023-04079-6","volume":"49","author":"S Chen","year":"2024","unstructured":"Chen S, Wan L, Zhao R et al (2024) Nomogram based on preoperative clinical and MRI features to estimate the microvascular invasion status and the prognosis of solitary intrahepatic mass-forming cholangiocarcinoma. Abdom Radiol (NY) 49:425\u2013436","journal-title":"Abdom Radiol (NY)"},{"key":"11296_CR18","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1007\/s11605-021-04911-8","volume":"25","author":"TL Sutton","year":"2021","unstructured":"Sutton TL, Billingsley KG, Walker BS et al (2021) Detection of tumor multifocality in resectable intrahepatic cholangiocarcinoma: defining the optimal pre-operative imaging modality. J Gastrointest Surg 25:2250\u20132257","journal-title":"J Gastrointest Surg"},{"key":"11296_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-020-00318-x","volume":"20","author":"X Ma","year":"2020","unstructured":"Ma X, Liu L, Fang J et al (2020) MRI features predict microvascular invasion in intrahepatic cholangiocarcinoma. Cancer Imaging 20:40","journal-title":"Cancer Imaging"},{"key":"11296_CR20","doi-asserted-by":"publisher","first-page":"6846","DOI":"10.1007\/s00330-021-07793-1","volume":"31","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Zhou G, Zhang J, Xu C, Wang X, Xu P (2021) Radiomics signature on dynamic contrast-enhanced MR images: a potential imaging biomarker for prediction of microvascular invasion in mass-forming intrahepatic cholangiocarcinoma. Eur Radiol 31:6846\u20136855","journal-title":"Eur Radiol"},{"key":"11296_CR21","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41392-023-01317-7","volume":"8","author":"GM Shi","year":"2023","unstructured":"Shi GM, Huang XY, Wu D et al (2023) Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study. Signal Transduct Target Ther 8:106","journal-title":"Signal Transduct Target Ther"},{"key":"11296_CR22","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1053\/j.gastro.2009.06.003","volume":"137","author":"S Roayaie","year":"2009","unstructured":"Roayaie S, Blume IN, Thung SN et al (2009) A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology 137:850\u2013855","journal-title":"Gastroenterology"},{"key":"11296_CR23","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1159\/000521747","volume":"11","author":"S Park","year":"2022","unstructured":"Park S, Lee Y, Kim H et al (2022) Subtype classification of intrahepatic cholangiocarcinoma using liver MR imaging features and its prognostic value. Liver Cancer 11:233\u2013246","journal-title":"Liver Cancer"},{"key":"11296_CR24","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1007\/s00330-017-5196-y","volume":"28","author":"SY Choi","year":"2018","unstructured":"Choi SY, Kim YK, Min JH et al (2018) Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging. Eur Radiol 28:2549\u20132560","journal-title":"Eur Radiol"},{"key":"11296_CR25","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jhep.2017.04.024","volume":"67","author":"S Lee","year":"2017","unstructured":"Lee S, Kim SH, Lee JE, Sinn DH, Park CK (2017) Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma. J Hepatol 67:526\u2013534","journal-title":"J Hepatol"},{"key":"11296_CR26","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.diii.2020.09.001","volume":"101","author":"M Benchoufi","year":"2020","unstructured":"Benchoufi M, Matzner-Lober E, Molinari N, Jannot AS, Soyer P (2020) Interobserver agreement issues in radiology. Diagn Interv Imaging 101:639\u2013641","journal-title":"Diagn Interv Imaging"},{"key":"11296_CR27","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1007\/s00261-023-03847-8","volume":"48","author":"S Chen","year":"2023","unstructured":"Chen S, Wan L, Zhao R et al (2023) Predictive factors of microvascular invasion in patients with intrahepatic mass-forming cholangiocarcinoma based on magnetic resonance images. Abdom Radiol (NY) 48:1306\u20131319","journal-title":"Abdom Radiol (NY)"},{"key":"11296_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-09035-5","volume":"21","author":"Y Chen","year":"2021","unstructured":"Chen Y, Liu H, Zhang J et al (2021) Prognostic value and predication model of microvascular invasion in patients with intrahepatic cholangiocarcinoma: a multicenter study from China. BMC Cancer 21:1299","journal-title":"BMC Cancer"},{"key":"11296_CR29","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1007\/s11605-018-4052-y","volume":"23","author":"P Addeo","year":"2019","unstructured":"Addeo P, Jedidi I, Locicero A et al (2019) Prognostic impact of tumor multinodularity in intrahepatic cholangiocarcinoma. J Gastrointest Surg 23:1801\u20131809","journal-title":"J Gastrointest Surg"},{"key":"11296_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000511384","volume":"10","author":"A Surov","year":"2021","unstructured":"Surov A, Pech M, Omari J et al (2021) Diffusion-weighted imaging reflects tumor grading and microvascular invasion in hepatocellular carcinoma. Liver Cancer 10:10\u201324","journal-title":"Liver Cancer"},{"key":"11296_CR31","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/jmri.26566","volume":"50","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Wang X, Xu C et al (2019) Mass-forming intrahepatic cholangiocarcinoma: can diffusion-weighted imaging predict microvascular invasion? J Magn Reson Imaging 50:315\u2013324","journal-title":"J Magn Reson Imaging"},{"key":"11296_CR32","doi-asserted-by":"crossref","unstructured":"Zhang Y, Yang C, Qian X, Dai Y, Zeng M (2024) Evaluate the microvascular invasion of hepatocellular carcinoma (\u2264\u20095\u2009cm) and recurrence free survival with gadoxetate disodium-enhanced MRI-based habitat imaging. J Magn Reson Imaging 60:1664\u20131675","DOI":"10.1002\/jmri.29207"},{"key":"11296_CR33","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/jmri.22876","volume":"35","author":"KA Kim","year":"2012","unstructured":"Kim KA, Kim MJ, Jeon HM et al (2012) Prediction of microvascular invasion of hepatocellular carcinoma: usefulness of peritumoral hypointensity seen on gadoxetate disodium-enhanced hepatobiliary phase images. J Magn Reson Imaging 35:629\u2013634","journal-title":"J Magn Reson Imaging"},{"key":"11296_CR34","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.3390\/cancers13102368","volume":"13","author":"J Wei","year":"2021","unstructured":"Wei J, Jiang H, Zeng M et al (2021) Prediction of microvascular invasion in hepatocellular carcinoma via deep learning: a multi-center and prospective validation study. Cancers (Basel) 13:2368","journal-title":"Cancers"},{"key":"11296_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100875","volume":"14","author":"C Zhang","year":"2021","unstructured":"Zhang C, Zhao R, Chen F, Zhu Y, Chen L (2021) Preoperative prediction of microvascular invasion in non-metastatic hepatocellular carcinoma based on nomogram analysis. Transl Oncol 14:100875","journal-title":"Transl Oncol"},{"key":"11296_CR36","doi-asserted-by":"publisher","first-page":"W253","DOI":"10.2214\/AJR.13.10595","volume":"203","author":"CT Chou","year":"2014","unstructured":"Chou CT, Chen RC, Lin WC, Ko CJ, Chen CB, Chen YL (2014) Prediction of microvascular invasion of hepatocellular carcinoma: preoperative CT and histopathologic correlation. AJR Am J Roentgenol 203:W253\u2013W259","journal-title":"AJR Am J Roentgenol"},{"key":"11296_CR37","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s13244-024-01741-5","volume":"15","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, Wu F, Hou K et al (2024) MR radiomics to predict microvascular invasion status and biological process in combined hepatocellular carcinoma-cholangiocarcinoma. Insights Imaging 15:172","journal-title":"Insights Imaging"},{"key":"11296_CR38","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1002\/hep4.1774","volume":"5","author":"YY Kim","year":"2021","unstructured":"Kim YY, Yeom SK, Shin H et al (2021) Clinical staging of mass-forming intrahepatic cholangiocarcinoma: computed tomography versus magnetic resonance imaging. Hepatol Commun 5:2009\u20132018","journal-title":"Hepatol Commun"},{"key":"11296_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.109189","volume":"130","author":"Y Tsujita","year":"2020","unstructured":"Tsujita Y, Sofue K, Komatsu S et al (2020) Prediction of post-hepatectomy liver failure using gadoxetic acid-enhanced magnetic resonance imaging for hepatocellular carcinoma with portal vein invasion. Eur J Radiol 130:109189","journal-title":"Eur J Radiol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-024-11296-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-024-11296-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-024-11296-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T15:41:56Z","timestamp":1749829316000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-024-11296-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":39,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["11296"],"URL":"https:\/\/doi.org\/10.1007\/s00330-024-11296-0","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,19]]},"assertion":[{"value":"12 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Mengsu Zeng.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"One of the authors (Yunfei Zhang) has significant statistical expertise.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}